Clinical trials: BDD
Cholecystitis, Acute, Cholecystitis, Chronic
BDD With UDCA Therapy After Laparoscopic Cholecystectomy
Prospective Study for the Effects of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycolic Acid Therapy on Liver Function and Quality of Life After Laparoscopic Cholecystectomy Primary endpoint: peak level of postoperative AST…
- Trial name
- BULQ-LC (NCT03578055)
- Testing
- BDD with UDCA
- Where
- South Korea
- Volunteers
- 172 people
- Sponsor
- Ewha Womans University Mokdong Hospital
Body Dysmorphic Disorder, BDD
Internet Delivered CBT for Body Dysmorphic Disorder
To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.
- Trial name
- NCT02010619
- Testing
- Cognitive behavior therapy, Supportive therapy
- Where
- Sweden
- Volunteers
- 94 people
- Sponsor
- Karolinska Institutet
Obsessive Compulsive Disorder, Body Dysmorphic Disorder
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
To examine the effectiveness and clinical care outcomes of cognitive-behavioral therapy interventions at Massachusetts General Hospital (MGH).
- Conditions
- Obsessive Compulsive Disorder, Body Dysmorphic Disorder, Tourette Syndrome, Trichotillomania
- Trial name
- NCT01075672
- Testing
- Cognitive behavioral therapy (CBT)
- Where
- United States
- Volunteers
- 250 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorphic Disorder, Obsessive-compulsive Disorder
Oxytocin Administration in BDD and OCD
The purpose of the current study is to investigate the effect of an acute administration of intranasal oxytocin, relative to placebo, on social cognitive impairments among individuals with body dysmorphic disorder and…
- Trial name
- NCT02671266
- Testing
- Oxytocin
- Where
- United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Orthognathic Surgical Procedures, Psychiatric Disorders
Incidence of Body Dysmorphic Disorder (BDD) in a Population of Patients Undergoing Orthognathic Surgery
Assessment of the incidence of Body dismorphic disorder in a population candidated to orthognathic surgery
- Conditions
- Orthognathic Surgical Procedures, Psychiatric Disorders, Prognathism
- Trial name
- IBDOS (NCT06879275)
- Testing
- Questionnaire and Physical Exam
- Where
- Italy
- Volunteers
- 90 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Body Dysmorphic Disorder, Steroid Abuse
CBT for Muscle Dysmorphia and Steroid Abuse: A Randomized Controlled Trial
The goal of this clinical trial is to evaluate the effectiveness of cognitive behavioral therapy (CBT) in treating muscle dysmorphia (MD) under body dysmorphic disorder (BDD) and steroid/performance-enhancing drug (PED) abuse in…
- Conditions
- Body Dysmorphic Disorder, Steroid Abuse, Body Dysmorphic Disorder (BDD), Subtype: Muscle Dysmorphia
- Trial name
- NCT06781853
- Testing
- Cognitive Behavioral Therapy (CBT)
- Where
- Turkey (Türkiye)
- Volunteers
- 71 people
- Sponsor
- Uskudar University
Dysmorphic Disorder (BDD), Congenital Labia Majora Hypotrophy
To Assess The Performance And Tolerance Of Janesse 20 In The Volume Restoration Of Labia Majora
The use of hyaluronic acid (HA)-based fillers administered by injection to obtain Labia Majora augmentation is performed by many surgeons and gynaecologists in Europe, US and other countries, but few studies have investigated the…
- Conditions
- Dysmorphic Disorder (BDD), Congenital Labia Majora Hypotrophy, Post-menopausal Labia Majora Hypotrophy
- Trial name
- NCT04936763
- Testing
- Janesse 20 (Cross-linked Hyaluronic Acid)
- Where
- 2 sites in Italy, Romania
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- I.R.A. Istituto Ricerche Applicate S.p.A.
Obsessive-Compulsive Disorder, Illness Anxiety Disorder
Study of Dextromethorphan in OCD and Related Disorders
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders.
- Conditions
- Obsessive-Compulsive Disorder, Illness Anxiety Disorder, Body Dysmorphic Disorders, Somatic Symptom Disorder
- Trial name
- NCT04899687
- Testing
- Fluoxetine, Dextromethorphan
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Stanford University
Body Dysmorphic Disorder
Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder
The purpose of this study is to develop and test the effectiveness of Cognitive-Behavioral Therapy (CBT) for children and adolescents suffering from Body Dysmorphic Disorder.
- Trial name
- NCT01002326
- Testing
- Cognitive-Behavioral Therapy
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorphic Disorders
Understanding Daily Changes in BDD Risk Using Smartphones
Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD.
- Trial name
- NCT04254575
- Testing
- None, observational study only (no interventions)
- Where
- United States
- Volunteers
- 87 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorphic Disorder
Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)
The aim of the research is to determine if Cognitive Behaviour Therapy (CBT) specific for BDD is more effective than a credible non-specific form of CBT for treating BDD and its delusional variant in adults aged 17 or over.
- Trial name
- NCT00871143
- Testing
- CBT specific for BDD, Non specific CBT
- Where
- United Kingdom
- Volunteers
- 46 people
- Sponsor
- Institute of Psychiatry, London
Metabolic-associated Fatty Liver Disease (MAFLD)
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
The goal of this observational study is to learn the effectiveness and safety of the use of Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the pathogenetic therapy of metabolic-associated fatty liver disease…
- Trial name
- NCT06078722
- Where
- 7 sites in Kazakhstan
- Volunteers
- 264 people
- Sponsor
- Kazakh Association of Internal Medicine Specialists
Anxiety Disorders, Somatoform Disorders
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
This study's primary aim is to compare time to relapse and relapse rates in responders to acute escitalopram who are then randomized to placebo versus continuation treatment with escitalopram.
- Trial name
- NCT00149799
- Testing
- Escitalopram
- Where
- 2 sites in United States
- Volunteers
- 100 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorhpic Disorder
Internet Cognitive Behavior Therapy (CBT) for Body Dysmorphic Disorder (BDD)
The primary aim is to develop, and test the feasibility, of a novel and protocol-based cognitive behaviour therapy (CBT) treatment for body dysmorphic disorder (BDD) administered via the Internet.
- Trial name
- NCT01850433
- Testing
- Internet based CBT for body dysmorphic disorder
- Where
- Sweden
- Volunteers
- 23 people
- Sponsor
- Karolinska Institutet
Body Dysmorphic Disorders
TMS Visual Modulation in Body Dysmorphic Disorder
The goal of this observational study is to test the effects of a type of noninvasive brain stimulation called transcranial magnetic stimulation (TMS) on visual processing in adults with body dysmorphic disorder symptoms when…
- Trial name
- EMPAC-BDD (NCT05607121)
- Testing
- intermittent theta burst stimulation, continuous theta burst stimulation
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- Centre for Addiction and Mental Health
Body Dysmorphic Disorder
Perceptual Abnormalities and Their Malleability in BDD
A core symptom of body dysmorphic disorder (BDD) is perceptual distortions for appearance, which contributes to poor insight and delusionality, limits engagement in treatment, and puts individuals at risk for relapse.
- Trial name
- NCT04373629
- Testing
- attentional modulation, perceptual modulation, naturalistic viewing
- Where
- Canada
- Volunteers
- 146 people, healthy volunteers welcome
- Sponsor
- Centre for Addiction and Mental Health
Obsessive-Compulsive Disorder, Body Dysmorphic Disorders
Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.
The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD).
- Conditions
- Obsessive-Compulsive Disorder, Body Dysmorphic Disorders, Anxiety Disorders
- Trial name
- NCT06346301
- Testing
- Imagery rescripting
- Where
- Netherlands
- Volunteers
- 36 people
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Body Dysmorphic Disorder
AI Screening for BDD in Aesthetic Surgery: Enhancing Safety and Outcomes
The goal of this observational study is to evaluate the effectiveness of an AI-powered screening tool for Body Dysmorphic Disorder (BDD) among patients seeking aesthetic surgery.
- Trial name
- AI (NCT06584305)
- Testing
- AI-Powered Body Dysmorphic Disorder Screening Procedure
- Where
- Argentina
- Volunteers
- 3,722 people, healthy volunteers welcome
- Sponsor
- Bukret Plastic Surgery
Body Dysmorphic Disorders
Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder
The investigators are developing and testing a Smartphone-based cognitive behavioral therapy (CBT) "app" for body dysmorphic disorder (BDD).
- Trial name
- NCT03221738
- Testing
- App-Based Cognitive Behavioral Therapy
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Massachusetts General Hospital
Body Dysmorphic Disorder
CBT as an Adjunct to SRIs in the Treatment of BDD
The research project is a controlled pilot study of the efficacy of cognitive-behavioral therapy (CBT) as an adjunct to serotonin reuptake inhibitor (SRI) pharmacotherapy in body dysmorphic disorder (BDD).
- Trial name
- NCT00211809
- Testing
- Cognitive Behavioral Therapy, Venlafaxine
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Icahn School of Medicine at Mount Sinai